Release Date: July 12, 2017
Expiration date: January 12, 2018
Estimated Time to Complete Activity: 1.0 hour
CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
CME for MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
OVERVIEW
The indications for TAVR have changed since its inception. In this webcast, experts discuss the SURTAVI trial and the SAPIEN 3 study in intermediate-risk patients as well as the outcomes of TAVR and SAVR. The safety and complications of the procedure are explored, as well as the potential to improve patient outcomes in light of the evolving indications of TAVR. In order to be successful in TAVR, the consensus is that the field should increase the hospitals offering the procedure, utilize the heart team effectively, improve education of the providers, and provide guidance on the criteria for patient selection.
LEARNING OBJECTIVES
After viewing this webcast, participants will be able to:
- Discuss the importance of the evolution of TAVR and recent trial results.
- Explain how the use of TAVR has changed over the last couple of years.
- Describe the key components of successful TAVR programs.
TARGET AUDIENCE
This activity is designed for interventional cardiologists, cardiac surgeons, clinical cardiologists, vascular medicine specialists, and other healthcare professionals.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
FACULTY DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E) Equity (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Susheel Kodali: (C/H/S) Edwards Lifesciences, Thubrikar Aortic Valve Inc., Claret Medical, Meril Lifesciences, VS MED Tech
Michael J. Reardon: (C/H/S) Medtronic
Vinod H. Thourani: (G/R) Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic (C/H/S) Edwards Lifesciences, Abbott Vascular, Gore Vascular
Planning Committee
Arielle Gelardi (Planner)
(S) Cardiovascular Research Foundation
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation. It is supported through educational grants from Medtronic Inc. and Edwards Lifesciences and was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Arielle Gelardi at agelardi@crf.org